Halliburton Co
XMUN:HAL
तय करें कि किस कीमत पर खरीदना आपके लिए उचित होगा। तैयार रहने में हम आपकी मदद करेंगे।
|
H
|
Halliburton Co
XMUN:HAL
|
US |
|
T
|
Thonburi Medical Centre PCL
SET:KDH
|
TH |
|
3P Learning Ltd
F:73P
|
AU |
|
Unipol Assicurazioni SpA
MIL:UNI
|
IT |
|
A
|
Amadeus IT Group SA
XMUN:AI3A
|
ES |
|
W
|
Welcron Hantec Co Ltd
KOSDAQ:076080
|
KR |
|
UT Group Co Ltd
TSE:2146
|
JP |
|
Cytek Biosciences Inc
F:8EQ
|
US |
|
S
|
Sdi Group PLC
F:SD0
|
UK |
|
AbL Diagnostics SA
PAR:ABLD
|
FR |
|
W
|
Westwater Resources Inc
F:UCCP
|
US |
|
Virco Mfg Corp
NASDAQ:VIRC
|
US |
|
BTQ Technologies Corp
F:NG3
|
CA |
|
Spartacus Acquisition Corp II
NASDAQ:TMTS
|
US |
|
H
|
Helen of Troy Ltd
XMUN:HT2
|
BM |
|
G
|
Glow Lifetech Corp
F:9DO
|
CA |
|
BeOne Medicines AG
NASDAQ:ONC
|
CH |
|
Endesa SA
F:ENA
|
ES |
अर्निंग्स कॉल
नवीनतम वित्तीय परिणाम कॉन्फ़्रेंस कॉल
Revenue: Halliburton reported second-quarter revenue of $5.7 billion, up 6% sequentially, with adjusted operating margin at 12%.
International strength: International revenue hit $3.4 billion, up 6% year over year, and management said it was the highest second-quarter international revenue in more than a decade despite Middle East disruption.
North America recovery: North America revenue was $2.3 billion, flat year over year but up 7% sequentially, with management seeing improving activity, better pricing and more technology adoption.
Guidance: For Q3, Halliburton expects C&P revenue to be flat to down 2% and margin to improve 125 to 175 basis points; D&E revenue to be down 3% to 5% with margin up 25 to 75 basis points.
Cash return: The company generated $824 million of operating cash flow, $668 million of free cash flow, and repurchased about $200 million of stock in the quarter.
Outlook: Management stayed constructive on 2026 and beyond, saying international growth outside the Middle East should be low double digits this year and that the company may be ahead of schedule on its international growth-engine target.